Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome-Reference-Cited by-同舟云学术

Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome

Published:2016-06 Issue:6 Volume:25 Page:638-645
ISSN:1540-9996
Container-title:Journal of Women's Health
language:en
Short-container-title:Journal of Women's Health

Author:

Adeniji Adeola A.¹,Essah Paulina A.²,Nestler John E.²³⁴,Cheang Kai I.¹⁴

Affiliation:

1. Department of Pharmacotherapy & Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.

2. Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, Virginia.

3. Department of Obstetrics and Gynecology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia.

4. Virginia Commonwealth University, Institute for Women's Health, Richmond, Virginia.

Publisher

Mary Ann Liebert Inc

Subject

General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jwh.2015.5418

Reference35 articles.

1. Polycystic Ovary Syndrome

2. Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome

3. Epidemiology and Adverse Cardiovascular Risk Profile of Diagnosed Polycystic Ovary Syndrome

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic management for polycystic ovary syndrome: Hirsutism and acne;Polycystic Ovary Syndrome;2024

2. Кардиоваскулярные эффекты метформина: в центре внимания метаболизм жировой ткани;Ateroscleroz;2022-09-30

3. A randomized sham-controlled trial of manual acupuncture for infertile women with polycystic ovary syndrome;Integrative Medicine Research;2022-06

4. Markers of insulin resistance in Polycystic ovary syndrome women: An update;World Journal of Diabetes;2022-03-15

5. The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 4: Sex- and Gender-Unique Disparities: CVD Across the Lifespan of a Woman;CJC Open;2022-02